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Isolation of Lactobacillus from Periodontally Healthy Subjects and its Antimicrobial 
Activity against Periodontal Pathogens
(Pemencilan Lactobacillus pada Subjek Gusi Sihat dan Aktiviti Antimikrobnya Terhadap Patogen Gusi)
AzIzAH AHMAd FAuzI, zAleHA SHAFIeI*, BAdIAH BAHArIn & nurulHudA MoHd
ABSTrACT
Bacteriocin or Bacteriocin like inhibitory substances (BLIS) is a protein antibiotic that has a relatively narrow spectrum 
of killing activity. It could potentially serve as a natural alternative to antibiotics in reducing the development of 
multi-drug resistant bacteria. Antimicrobial activity of the strains of lactobacillus sp. isolated from healthy subjects 
(test strains) against Aggregatibacter actinomycetemcomitans and other periodontal pathogens (indicator strains) 
isolated from subgingival plaques of aggressive periodontitis patients were determined by using deferred antagonism 
test and agar-well diffusion method. Strains of lactobacillus sp., Aggregatibacter actinomycetemcomitans and black 
pigmented bacteria were selectively isolated from TJA, TSBV and TSBA agars, respectively. Mean diameter zone of 
inhibition of at least 10 mm was considered as positive results for both methods. Out of 25 strains of lactobacillus 
sp. screened, only eight test strains of lactobacillus sp. showed the specific antimicrobial activity against certain 
strains of indicator periodontal pathogens during deferred antagonism test. However, out of eight potential strains, 
only three strains, which were lactobacillus sp. strain S, lactobacillus sp. strain V and lactobacillus sp. strain W 
consistently showed positive inhibitory activity against black pigmented bacteria by deferred antagonism test and 
agar-well diffusion method. Therefore, these three strains should be considered as potential BLIS producer strains 
for further study. 
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ABSTrAK
Bakteriosin atau bahan perencat seakan bakteriosin (BLIS) merupakan protein antibiotik yang mempunyai medan 
aktiviti pembunuhan yang sempit. Ia berpotensi sebagai produk alternatif antibiotik semula jadi dalam mengurangkan 
peningkatan bakteria yang rentan terhadap pelbagai dadah. Aktiviti antimikrob strain lactobacillus sp. yang 
dipencilkan daripada subjek sihat (strain ujian) terhadap strain Aggregatibacter actinomycetemcomitans dan 
pathogen gusi yang lain (strain penentu) yang dipencilkan daripada plak subgingiva pesakit periodontitis agresif 
ditentukan dengan menggunakan kaedah ujian penentangan tertangguh dan resapan telaga-agar. Strain lactobacillus 
sp., Aggregatibacter actinomycetemcomitans dan bakteria pigmen hitam telah dipencilkan secara terpilih pada 
agar TJA, TSBV dan TSBA. Purata diameter zon perencatan yang lebih atau sama dengan 10 mm merupakan hasil 
positif bagi kedua-dua kaedah. Sebanyak 25 strain lactobacillus sp. telah dikaji, namun hanya lapan strain ujian 
lactobacillus sp. telah menunjukkan aktiviti antimikrob yang spesifik terhadap strain pathogen gusi tertentu semasa 
ujian penentangan tertangguh. Walau bagaimanapun, daripada lapan strain yang berpotensi tersebut, hanya tiga 
strain iaitu lactobacillus sp. strain S, lactobacillus sp. strain V and lactobacillus sp. strain W secara tetap telah 
menunjukkan aktiviti perencatan yang positif terhadap bakteria pigmen hitam menggunakan kaedah ujian penetangan 
tertangguh dan resapan telaga-agar. Oleh yang demikian, ketiga-tiga strain tersebut seharusnya dianggap berpotensi 
sebagai penghasil BLIS untuk kajian lanjut.
Kata kunci: Aktiviti antimikrob; lactobacillus sp.; patogen gusi; subjek dengan gusi sihat
InTroduCTIon 
In Malaysia, as in many other developing nations, 
periodontal disease is a problem of worrying magnitude 
(dental Services division 1993). In an epidemiological 
survey of 9,047 adults in Malaysia reported in 1977, 72% 
had periodontal disease ranging from mild inflammation, 
intense gingivitis and destructive periodontal disease 
(dental division 1978). nowadays, increasing evidence 
for early onset periodontitis showed that the younger 
population also has an increase risk of developing 
periodontitis (oliver et al. 1998; Taiyeb Ali & razak 
2000). About 4.8% of patients who were referred to 
Periodontal department, university of Malaya had early 
onset periodontitis and 1.9% among these patients were 
diagnosed with aggressive periodontitis (Taiyeb Ali & 
razak 2000). A study done in nigeria showed the most 
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frequently lost teeth in periodontal diseased patients were 
incisors (dosumu et al. 2003).
 The responsible flora in aggressive periodontitis is 
polymorphic, Gram-negative and microaerophilic or strictly 
anaerobic bacteria. About 10-20 species were suggested to 
play a role in the pathogenesis of periodontal destruction 
(darby 2001). Aggregatibacter actinomycetemcomitans 
(formally Actinobacillus actinomycetemcomitans) has 
been frequently related to localized juvenile periodontitis 
(Wilson & Henderson 1995; zambon 1985). The 
microbiology of generalized juvenile periodontitis is more 
complex and is associated with Porphyromonas gingivalis 
(10-15%) and other Gram-negative bacilli (Eikenella 
corrodens, Capnocytophaga sp., Aggregatibacter 
actinomycetemcomitans) (Fine et al. 1999). due to the fact 
that aggressive periodontitis caused by bacteria such as 
Aggregatibacter actinomycetemcomitans, Porphyromonas 
gingivalis and other Gram-negative bacilli, it generally 
affecting young adults, early elimination of these bacteria 
will prevent progression of the disease. 
 Probiotics has been found to be beneficial to the host 
health which is primarily used for the management of 
intestinal tract problem. In recent years, probiotics has been 
used as a treatment to promote oral health. The organisms 
that were used as probiotics are primarily certain species of 
lactobacilli, Bifidobacteria, Saccharomyces sp. but some 
Streptococci, enterococci and commensal Escherichia 
coli which have been claimed to have beneficial effects in 
certain situations (Caglar et al. 2005; reid et al. 2003).
 The modes of action of probiotics function by 
preventing adhesion of pathogens to host tissue, stimulation 
and modulation of the mucosal immune system, modulation 
of cell proliferation on apoptosis, improvement of intestinal 
barrier integrity and killing or inhibiting the growth of 
pathogens through bactreriocins production or other 
products (peroxide) which are antagonistic towards 
pathogenic bacteria ( Geier et al. 2007; Picard et al. 2005). 
Bacteriocins are peptide or proteinaceous antimicrobials 
produced by bacteria capable of inhibiting the growth 
or killing other bacteria without affecting itself (Tagg et 
al. 1976). The term BlIS has been adopted and used for 
bacterial products that have bacteriocin-like inhibitory 
effects although they may not be completely characterized 
(Walls et al. 2003). 
 Increasing use of probiotic bacteria (e.g. Lactobacillus 
and Bifidobacteria) to improve gastrointestinal health has 
prompted interest in the utility of this approach for oral 
applications. Moreover, the rapid rise of multiresistant 
bacteria pathogens results in continuous effort to 
identify alternative methods of combating infection. 
BlIS could potentially serve as a natural alternative to 
antibiotics. unlike classical antibiotics, bacteriocin has 
a relatively narrow spectrum of killing activity, resulting 
in a reduction in the intensity of selection for resistance 
(Bowe et al. 2006). Periodontal disease can be reduced by 
investigating the potential of BlIS-producing Lactobacilli 
that have the capability to inhibit Aggregatibacter 
actinomycetemcomitans activity and other periodontal 
pathogens. Therefore, the aim of this study was to 
determine the antimicrobial activity of Lactobacillus sp. 
isolated from healthy subjects against Aggregatibacter 
actinomycetemcomitans and other periodontal pathogens 
isolated from aggressive periodontitis patients.
MATerIAlS And MeTHodS
ClInICAl exAMInATIon oF THe SuBjeCTS
Seven subjects with aggressive periodontitis and 10 
volunteers with periodontal healthy between 18 and 35 
years of age were recruited. This study was approved by 
the research ethic Committee of universiti Kebangsaan 
Malaysia Medical Centre and written consent was obtained 
from the subjects before obtaining saliva and subgingival 
plaques. 
 The periodontally healthy subjects were defined as 
having at least 24 natural teeth with less than 20% of sites 
with bleeding on probing (BoP) and plaque score and no 
probing pocket depth (Pd) and clinical attachment level 
(CAl) of more than 3 ml. The aggressive periodontitis 
subjects were diagnosed as having at least 20 natural teeth 
with less than 20% of sites with BoP and plaque score and 
minimum of 6 teeth with an interproximal site with Pd more 
than 4 ml and CAl between 5 and 10 ml. Both groups 
did not have any history of systemic disease or medical 
conditions that would require antibiotic prophylaxis for 
routine dental procedures. exclusion criteria include 
pregnant women, smoking subjects and individuals who 
had taken antibiotics in the previous 3 months. 
ISolATIon oF TeST And IndICATor STrAInS
The test strains (Lactobacillus sp.) were isolated from the 
saliva of healthy subjects who chewed a piece of paraffin 
film for 2 min to stimulate saliva secretion. The indicator 
strains were isolated from subgingival plaques of patients 
with aggressive periodontitis. Subgingival plaque samples 
were obtained from two deepest periodontal pockets 
of upper incisors where isolation was easily achieved. 
Isolation of a tooth was done by using sterile cotton 
rolls and the supragingival region of the tooth surface to 
be sampled were cleaned and dried with cotton pellets. 
Subgingival plaque sample from the deepest pocket of 
a subject was obtained by using fine sterile paper point 
which was inserted in a periodontal pocket for 60 s. 
Then, the paper point was transferred into a test tube 
containing 2 ml of sterilized phosphate buffered saline 
solution (pH 7.3). The next paper point that was inserted 
into the second site of the deepest pocket was transferred 
into a test tube containing 2 ml of 0.9% sodium chloride 
(Sigma, uSA) (pH 7.3). The stimulated saliva and both of 
the subgingival plaque samples were processed within 2 
h of sample collection.
 All samples collected were vortex mixed for one 
min. A 10-fold from 10-1 to 10-5 dilution of each sample 
was made. About 0.1 ml of diluted stimulated saliva was 
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plated on a tomato juice agar (pH 5.0) (TjA) (Sigma, uSA), 
a selective medium for Lactobacillus. The triplicate of 
the tomato juice agar plates were incubated aerobically 
at 37oC for 72 to 96 h (Charlton & Spies 1956). Ten-fold 
serially diluted subgingival plaque samples (0.1 ml) from 
aggressive periodontitis patient was plated on tryptic soy 
bacitracin vancomycin (TSBV) (oxoid, uSA) and tryptic 
soy blood agar (TSBA) (oxoid, uSA) to selectively isolate 
Aggregatibacter actinomycetemcomitans (Slots 1982) and 
black pigmented colonies, respectively. The distinct black 
colour colonies formed on the surface of TSBA were known 
as black pigmented bacteria. The plating was done in 
triplicates and all agar plates were incubated anaerobically 
at 37oC for 48 to 72 h. different patterns of colonies on 
selective media were characterized morphologically 
according to configuration, margin, elevation, diameter and 
colour. different colonies of Lactobacillus sp. were selected 
as test strains. different colonies of Aggregatibacter 
actinomycetemcomitans and black pigmented bacteria 
were selected as indicator strains for deferred antagonism 
test and agar-well diffusion methods. The potential strains 
of BlIS-producing Lactobacillus and the indicator strains 
were identified by Gram staining. 
IN VITRO AnTIMICroBIAl ACTIVITY TeSTInG
Antimicrobial activity of Lactobacillus against 
Aggregatibacter actinomycetemcomitans and black 
pigmented bacteria were assessed using deferred 
antagonism test and agar-well diffusion methods. deferred 
antagonism test (Balakrishnan et al. 2001; Modified Tagg & 
Bannister 1979) was performed on TSYCa media prepared 
by a mixture of tryptic soy broth (Becton dickinson, uSA) 
with 1.5% bacteriological agar (difco laboratories, uSA), 
2% yeast extract (difco laboratories, uSA) and 0.25% 
CaCo3 (difco laboratories, uSA). Briefly, a standardized 
0.5 McFarland of the test strain culture was inoculated in 
a 1 cm wide diametric streak across the surface of TSYCa 
agar using a sterile cotton swab. Then, the plate agar 
containing the test strain was incubated at 37oC for 24 h. 
Macroscopically visible growth was removed by scraping 
with the edge of a glass slide. Then, the plate was inverted 
over a circle of chloroform-soaked filter paper in the lid of a 
petri dish. After 30 min, the plate was removed from the lid 
and exposed to the air for 15 min. After that, a standardized 
0.5McFarland of overnight (18 h, 37oC) purified culture 
of indicator strain was streaked at right angle to the line 
of original producer growth with a cotton swab. The same 
procedure was done in triplicates and all the TSYCa agar 
plates with the test and indicator strains were incubated at 
37oC for 24 h. The reduced growth of indicator strain in 
the vicinity of the area originally occupied by the growth 
of producer strain provided evidence of bacteriocin like 
inhibitory substance production (Tagg & Bannister 1979). 
The inhibition zone width of the indicator strain with at 
least 10 mm was considered significantly positive and was 
further investigated by agar-well diffusion method.
 For the agar-well diffusion method, 0.1 ml of 
standardized 0.5 McFarland individual indicator strain was 
inoculated and incubated at 37oC for 24 h onto a brain heart 
infusion (BHI) (oxoid, uSA) agar. Then, four wells of 7 mm 
diameter were filled with 100 μL of culture supernatant. 
The plates were incubated at 37oC for 24 h and zones of 
inhibition were measured in mm (Gaurav et al. 2010). The 
culture supernatant was prepared by propagating purified 
test strain in Todd Hewitt broth and incubated at 37oC for 
48 h. The cells were separated by centrifuging at 5,000 
rpm for 10 min. Cell free supernatant was passed through 
0.22 μm membrane filter and evaluated for antimicrobial 
activity (Aslim et al. 2005). The experiment was done 
in triplicate and the inhibitory activity of each test strain 
against each clinical sample of periodontal pathogens was 
measured and reported as mean diameter (mm) ± standard 
deviation (Sd). The inhibitory activity of test strain was 
considered significantly positive if the zone inhibition 
produced by the test strain against the indicator strain 
(periodontal pathogen) was at least 10 mm (Balakrishnan 
et al. 2001).
reSulTS And dISCuSSIon
A total of 25 test strains and 21 indicator strains were 
isolated from 10 selected periodontal healthy and 
seven aggressive periodontitis subjects, respectively. 
The distinct strains were selected based on different 
culture morphologies, sizes and colours. The test strains 
(Lactobacillus sp.) as well as the indicator strains of 
Aggregatibacter actinomycetemcomitans and black 
pigmented bacteria were obtained from serial dilution 
suspensions which were grown on selective medium 
of TjA, TSBV and TSBA, respectively. Aggregatibacter 
actinomycetemcomitans and black pigmented bacteria 
were chosen as indicator strains as they were generally 
accepted to be the principal etiological agent of aggressive 
periodontitis. All of 25 selected test strains (Lactobacillus 
sp.) obtained from TjA were tested for the BlIS activity 
against Aggregatibacter actinomycetemcomitans and black 
pigmented bacteria. The results obtained from deferred 
antagonism test showed that out of 25 Lactobacillus sp. 
strains tested, only eight test strains showed positive BlIS 
activities against six indicator strains. The other 17 test 
strains did not show any inhibitory effect against any of 
the periodontal pathogens. 
 overall, the results showed that the eight isolated test 
strains of Lactobacillus sp. showed specific antimicrobial 
activity against certain indicator strains. Lactobacillus 
strain l, n and V only inhibited black pigmented strain 
2C with mean diameter inhibitory zones (mm ± Sd) of 
11.67 ± 0.58 mm, 14.33 ± 4.04 mm and 15.33 ± 4.41 mm, 
respectively. Lactobacillus sp. strain S was capable of 
inhibiting the growth of black pigmented strain 2A and 2B 
with mean diameter zone of inhibition (mm ± Sd) of 16.67 
± 1.53 mm and 10.67 ± 3.46 mm, respectively. Moreover, 
Lactobacillus sp. strain H, P and x only inhibited the 
specific strains of Aggregatibacter actinomycetemcomitans 
22 
but not black-pigmented strains with mean diameter 
inhibitory zones (mm ± Sd) of 10.00 ± 2.00 mm (strain 1B), 
10.00 ± 2.00 mm (strain 1C) and 12.67 ± 3.21 mm (strain 
1A), respectively. These results indicated that only certain 
strains of Lactobacilli from oral cavity have potential to 
inhibit strains of indicator periodontal pathogens (Table 
1, and Figure 1(a)). However, Lactobacillus sp. strain 
W had the capability to inhibit both indicator strains 
with the mean diameter clear inhibitory zones (mm 
± Sd) were significantly positive for Aggregatibacter 
actinomycetemcomitans strain 1A (10.67 ± 0.28 mm) and 
black-pigmented strain 2A (12.67 ± 1.53 mm) (Table 1). 
This variation was due to these pathogens (Aggregatibacter 
actinomycetemcomitans and black pigmented bacteria) 
having the ability to produce its own BlIS to maintain their 
growth in oral cavity. 
 Apart from the deferred antagonism test, there 
were several other methods which can also be used to 
determine the production of BlIS. These methods include 
agar well diffusion method (Gaurav et al. 2010) and 
modification of the overlay technique (Hillman et al. 
1984). In the present study, the eight potential test strains 
of Lactobacillus sp. from deferred antagonism test were 
further investigated using well diffusion method. results 
obtained showed that only three strains inhibited growth 
of periodontal pathogens. The three potential test strains 
were Lactobacillus sp. strain S, Lactobacillus sp. strain 
V and Lactobacillus sp. strain W. Both Lactobacillus 
sp. strain V and Lactobacillus sp. strain W were capable 
of inhibiting indicator black pigmented strain 2A with 
mean diameter (mm ± Sd) of inhibitory zones of 10.33 
± 0.57 mm and 10.67 ± 2.08 mm, respectively. The 
mean diameter (mm ± Sd) of inhibitory zone produced 
by Lactobacillus sp. strain V against indicator black 
pigmented strain 2C was 10.33 ± 1.53 mm (Table 2, 
Figure 1(b)). The inhibition zones of at least 10 mm 
TABle 1. Mean diameter (mm) ± standard deviation (Sd) zone of inhibition for strains of Lactobacillus sp. 
against periodontal pathogen strains by deferred antagonism test
Aggregatibacter actinomycetemcomitans Black pigmented bacteria
1A 1B 1C 2A 2B 2C
H 0 10±2 0 0 0 0
l 0 0 0 0 0 11.67±0.58
n 0 0 0 0 0 14.33±4.04
P 0 0 10±2 0 0 0
S 0 0 0 16.67±1.53 10.67±3.46 0
V 0 1.67±2.89 9.33±1.53 7±3.61 6.33±4.04 15.33±4.51
W 10.67±2.08 0 0 12.67±1.53 2.65±0.58 4±3








 (a)  (b)
FIGure 1. deferred antagonism test (a) and agar-well diffusion method (b) demonstrating inhibitory 
activity of Lactobacillus sp. against indicator strains
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in diameter were significantly positive as suggested by 
Balakrishnan et al. (2001). BlIS-producing Lactobacillus 
(strain S, V and W) that produced inhibitory activity in 
both methods represented white to yellowish colonies 
with smooth margin (Figure 2). The same strain that 
gave positive results on deferred antagonism test also 
showed clear inhibitory zones on agar-well method with 
less than 10 mm and was considered as negative. The 
present findings showed that the deferred antagonism 
test was more effective as lactobacilli strains possessed 
antibacterial activity against more periodontal pathogens, 
while less active in agar-well diffusion method. These 
could be attributed to differences in the diffusion rate of 
bacteriocin in agar medium for both methods (Ahmad et 
al. 2004). BlIS-producing lactobacilli (strain S, V and W) 
had the most potential as BlIS producers as both methods 
showed positive results. TSYCa agar has been used for 
over 20 years for the detection of BlIS production by 
streptococci. The BlIS protein secreted by streptococci 
was relatively small molecules which can easily diffuse 
through agar (Walls et al. 2003). Thus, Lactobacillus sp. 
strain S, Lactobacillus sp. strain V and Lactobacillus sp. 
strain W were BlIS producers that may be important in 
periodontal disease prevention. 
 These potential test strains that showed clear zones of 
inhibition of at least 10 mm in both methods were further 
identified with Gram staining. The potential BlIS-producing 
lactobacilli were identified as Gram-positive coccobacilli 
and both potential indicator black pigmented strains 2A 
and 2C were identified as Gram-negative coccobacilli. 
However, further identification of these three potential test 
strains and the associate potential indicator strains (black 
pigmented bacteria strain 2A and 2C) were required for 
confirmation by using commercial biochemical test kit 
system API 20A. 
ConCluSIon
This study showed that bacteria isolated from the saliva of 
healthy individuals have potential in production of BlIS. 
These BlIS-producing bacteria (Lactobacillus sp. strain S, 
Lactobacillus sp. strain V and Lactobacillus sp. strain W) 
can be used as a natural alternative antibiotic in combating 
periodontal pathogens such as black pigmented bacteria. 
TABle 2. Mean diameter (mm) ± standard deviation (Sd) zone of inhibition for strains of Lactobacillus sp. against strains of 
periodontal pathogen by agar-well diffusion method
Aggregatibacter actinomycetemcomitans Black pigmented bacteria
1A 1B 1C 2A 2B 2C
H 0 2±2.65 0 0 0 0
l 0 0 0 0 0 1.33±1.15
n 0 0 0 0 0 1.33±1.53
P 0 0 0.67±1.15 0 0 0
S 0 0 0 10.33±0.58 1±1 0
V 0 0 0 0 0 10.33±1.53
W 2±1.73 0 0 10.67±2.08 0 4±3
x 3±2 0 0 0 0 0








FIGure 2. Culture morphology of the three strains of BlIS-producing Lactobacillus sp.
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Therefore, the purified bacteriocin produced by these 
strains can be used as an anti-periodontal disease agent 
and has the potential to be incorporated to mouthwash, 
toothpaste or in lozenges. replacement therapy using 
attenuated potential strains also can be used as another 
alternative in periodontal disease prevention.
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